Skip to main content
. Author manuscript; available in PMC: 2021 Aug 5.
Published in final edited form as: Adv Funct Mater. 2020 Feb 20;30(15):1908743. doi: 10.1002/adfm.201908743

Figure 7.

Figure 7.

In vivo antitumor efficacy of free ODN1826, CCMV-ODN1826, and control VLPs in a murine model of melanoma. A) Treatment schedule. B) Growth curves of melanoma tumors, showing mean tumor volumes ± standard deviations (n = 8–10). Statistical significance was determined by two-way ANOVA (***p < 0.001). C) Tumor growth kinetics for each treatment group. D) Survival curves. Statistical significance was determined using the long-rank (Mantel-Cox) test (***p < 0.001).